Elevation of plasma levels of fluorinated pyrimidines by guanosine 5′-monophosphate Masaaki IigoZiro YamaizumiAkio Hoshi Original Articles Pages: 1 - 4
Selective interactions of verapamil with anthraquinones in adriamycin-sensitive and-resistant murine and human tumour cell lines in vitro Elizabeth M. GibbyOdette BoyseBridget T. Hill Original Articles Pages: 5 - 7
Comparative in vitro toxicity of mitoxanatrone and adriamycin in human granulocyte-macrophage progenitor cells H.-G. MergenthalerP. BrühlE. Heidemann Original Articles Pages: 8 - 12
Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in rabbits J. W. PaxtonP. C. EvansR. M. Singh Original Articles Pages: 13 - 15
Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity R. M. BöhmerK. HoffmannG. Morstyn Original Articles Pages: 16 - 20
Reduction of vincristine toxicity by Cronassial K. HellmannG. E. HutchinsonK. Henry Original Articles Pages: 21 - 25
A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin Phillip A. ReeceIrene StaffordP. Grantley Gill Original Articles Pages: 26 - 32
Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics Michelle J. SobleRobert T. DorrSteven Breckenridge Original Articles Pages: 33 - 36
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809) Patrick J. CreavenStefan MadajewiczJoan Solomon Original Articles Pages: 37 - 40
Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies M. G. RosenblumJ. L. MurrayD. Carlo Original Articles Pages: 41 - 47
High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancer Richard OsborneBarrie EvansEve Wiltshaw Original Articles Pages: 48 - 52
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma J. WagstaffI. ToddD. Crowther Original Articles Pages: 53 - 58
Drug monitoring of etoposide (VP16-213) Karl-Heinz PflügerLothar SchmidtKlaus Havemann Original Articles Pages: 59 - 66
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors M. L. ZanetteU. TirelliM. D'Incalci Original Articles Pages: 67 - 70
Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapy Gérard MilanoMoise NamerJean-Noel Bruneton Original Articles Pages: 71 - 74
Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer Robert MilroyJeffrey CummingsStephen W. Banham Original Articles Pages: 75 - 77
Methotrexate (MTX) concentration in tumors following low-dose MTX Naomi J. WinickBarton A. KamenDale Coln Short Communication Pages: 78 - 80
Poly(I) · Poly(C), a potential drug carrier for the antitumor agent mitoxantrone: in vitro drug binding study Hans-Georg EichlerRobert MaderHugo Rainer Short Communication Pages: 81 - 82
Etoposide combination therapy for small cell carcinoma of the lung R. P. AbrattP. A. WillcoxR. H. Hewitson Short Communication Pages: 83 - 84
Metabolism of epidoxorubicin in animals: absence of glucuronidation P. A. MaessenK. B. MrossW. J. F. van der Vijgh Short Communication Pages: 85 - 87